Literature DB >> 11032628

Atypical form of non-Langerhans histiocytosis with disseminated brain and leptomeningeal lesions.

T Stojkovic1, J de Seze, C A Maurage, C Rose, J C Hache, P Vermersch.   

Abstract

An 18 year old girl presented with acute visual loss. T2 weighted brain MRI showed areas of hyperintensities in the thalamic nuclei, internal capsule, lentiform nuclei, the subarachnoidal spaces, and a retrobulbar infiltration. Analysis of CSF showed numerous foamy histiocytes without malignant cells, raised protein, and depressed glucose concentration. Biopsy of the right thalamus demonstrated aggregates of histiocytes with immunohistological and ultrastructural characteristics of non-Langerhans cell histiocytosis. The patient improved with chemotherapy and corticosteroids. After 3 months of treatment, CSF analysis showed no more histiocytes. Cytological examination of CSF can be helpful for the management of patients with extensive histiocytic infiltration.

Entities:  

Mesh:

Year:  2000        PMID: 11032628      PMCID: PMC1763411          DOI: 10.1136/jnnp.69.5.675

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  3 in total

Review 1.  Cerebral Erdheim-Chester disease: case report and review of the literature.

Authors:  Stefan Weidauer; Sebastian von Stuckrad-Barre; Edgar Dettmann; Friedhelm E Zanella; Heinrich Lanfermann
Journal:  Neuroradiology       Date:  2003-02-21       Impact factor: 2.804

Review 2.  Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature.

Authors:  Florence Lachenal; François Cotton; Hélène Desmurs-Clavel; Julien Haroche; Hervé Taillia; Nadine Magy; Mohamed Hamidou; Juan Salvatierra; Jean-Charles Piette; Denis Vital-Durand; Hugues Rousset
Journal:  J Neurol       Date:  2006-10-24       Impact factor: 4.849

Review 3.  Neuro-ophthalmologic complications of neoplastic leptomeningeal disease.

Authors:  Gabriella Szatmáry
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.